Nanobody-mediated imaging of the immune checkpoint LAG-3

Lecocq, Q. (Speaker), Zeven, K. (Contributor), De Vlaeminck, Y. (Contributor), Martens, S. (Contributor), Massa, S. (Contributor), Goyvaerts, C. (Contributor), Raes, G. (Contributor), Keyaerts, M. (Contributor), Breckpot, K. (Contributor), Devoogdt, N. (Contributor)

Activity: Talk or presentation › Talk or presentation at a conference

Period	18 Oct 2019
Event title	ORC day 2019
Event type	Conference
Degree of Recognition	National

Related content

Projects
Translational & Clinical Research : Visualizing immunosuppressive PD-L1 expression in tumors using anti PD-L1 sdAb PET-CT scan: a new strategy for accurate patient selection in targeted immune-activating cancer therapy
Project: Fundamental
FWO Hercules MZW: Platform for cell analysis after radioactivity based Molecular Imaging and targeted Therapy of cancer (PeRMIT)
Project: Fundamental
Nanobody-mediated imaging and blocking of the inhibitory receptor LAG-3
Project: Fundamental
The visualization of immunosuppressive PD-L1 expression by means of anti-PD-L1 Nanobody PET-CT scan: a new strategy for the accurate patient selection in immuno-activating oncological treatment
Project: Fundamental